Collaboration combines Lunit's AI expertise with Agilent's diagnostic leadership to revolutionize biomarker testing and enhance precision medicine capabilities
The AI system was tested on digital slides from breast, colon, stomach, and esophageal cancer cases
EBITDA grew by 11% on a YoY basis to Rs. 296 crore due to improved performance in CDMO Sterile Injectables, CRDMO and Generics
Aims to become India’s leading cancer testing company
Approximately half of all patients with metastatic breast cancer (mBC) express low levels of HER2
APAC region contributed around 50% of the in-vitro diagnostics market in 2022
There is also a growing interest in whole generation sequencing (WGS)
C2i Genomics expands its global reach and brings the first whole-genome sequencing minimal residual disease test to India
Crosscope Dx is a workflow integrated vendor-agnostic digital pathology platform that offers end-to-end digital pathology solutions with advanced workflow features
Dr. Bibikova is an international leader with over 25 years of experience in genomics industry
Subscribe To Our Newsletter & Stay Updated
